BBH.L
Latest Trade
196.00GBpChange
0.80(+0.41%)Volume
377,215Today's Range
-
196.0052 Week Range
-
204.00As of on the London Stock Exchange (LON) ∙ Minimum 15 minute delay
Previous Close | 195.20 |
|---|---|
Open | 196.00 |
Volume | 377,215 |
3M AVG Volume | 18.01 |
Today's High | 196.00 |
Today's Low | 195.00 |
52 Week High | 204.00 |
52 Week Low | 162.01 |
Shares Out (MIL) | 554.00 |
Market Cap (MIL) | 1,085.84 |
Forward P/E | -- |
Dividend (Yield %) | 2.81 |
BB Healthcare Trust To Declare Interim Dividend For FY2020 Of 2.50P
BB Healthcare Trust Says Renewed Multi-Currency Revolving Credit Facility
BB Healthcare Raises 46.3 Mln Stg Via Placing
BB Healthcare Trust plc is an investment trust. The Trust's investment objective is to provide shareholders with capital growth and income over the long term, through investment in listed or quoted global healthcare companies. It intends to invest in a concentrated portfolio of listed or quoted equities in the global healthcare industry. It may also invest in American depositary receipts or convertible instruments issued by such companies and may invest in, or underwrite, future equity issues by such companies. Its portfolio includes in industries, such as pharmaceuticals, biotechnology, medical devices and equipment, healthcare insurers and facility operators, information technology (where the product or service supports, supplies or services the delivery of healthcare), drug retail, consumer healthcare and distribution. Bellevue Asset Management AG serves as the portfolio manager and Bellevue Asset Management (UK) Ltd serves as an investment advisor to the Trust.
Industry
Misc. Financial Services
Contact Info
Mermaid HSE, 2 Puddle Dock
EC4V 3DB
United Kingdom
+44.20.76539690
http://www.bbhealthcaretrust.com/en/bb-healthcare-trustExecutive Leadership
Randeep Singh Grewal
Non-Executive Independent Chairman of the Board
Kate Blanche Mary Bolsover
Non-Executive Director
Josephine Dixon
Senior Non-Executive Independent Director
Paul Southgate
Non-Executive Independent Director
Justin Stebbing
Non-Executive Independent Director
Price To Earnings (TTM) | 7.15 |
|---|---|
Price To Sales (TTM) | 7.53 |
Price To Book (MRQ) | 1.08 |
Price To Cash Flow (TTM) | -- |
Total Debt To Equity (MRQ) | 2.53 |
LT Debt To Equity (MRQ) | 0.00 |
Return on Investment (TTM) | 15.81 |
Return on Equity (TTM) | 15.09 |
Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.